Girlandia Alexandre Brasil

Dr. Girlandia Alexandre Brasil


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2013 in Steroids
Verified
Journal Article
Closed access
JFJoão Vicente Maggioni Franquni
João Vicente Maggioni Franquni
ANAndrews Marques Do Nascimento
Andrews Marques Do Nascimento
ELEweliny Miranda de Lima
Eweliny Miranda de Lima
GBGirlandia Alexandre Brasil
Girlandia Alexandre Brasil
OHOtávio Arruda Heringer
Otávio Arruda Heringer
TATadeu Andrade
Tadeu Andrade

1 July 2018 in Nutrition
Verified
Journal Article
Closed access
GBGirlandia Alexandre Brasil
Girlandia Alexandre Brasil
MSMirian de Almeida Silva-Cutini
Mirian de Almeida Silva-Cutini
FMFlávia de Souza Andrade Moraes
Flávia de Souza Andrade Moraes
TPThiago de Melo Costa Pereira
Thiago de Melo Costa Pereira
EVElisardo Corral Vasquez
Elisardo Corral Vasquez
TATadeu Andrade
Tadeu Andrade

8 October 2014 in Planta Medica
Verified
Journal Article
Closed access
PDF file
GBGirlandia Alexandre Brasil
Girlandia Alexandre Brasil
SRSilas Nascimento Ronchi
Silas Nascimento Ronchi
ANAndrews Marques Do Nascimento
Andrews Marques Do Nascimento
ELEwelyne Miranda de Lima
Ewelyne Miranda de Lima
WRWanderson Romão
Wanderson Romão
TATadeu Andrade
Tadeu Andrade
The aims of this study were to evaluate the antihypertensive effects of the standardised methanolic extract of Carica papaya, its angiotensin converting enzyme inhibitory effects in vivo, its effect on the baroreflex and serum angiotensin converting enzyme activity, and its chemical composition. The chemical composition of the methanolic extract of C. papaya was evaluated by liquid chromatography-mass/mass and mass/mass spectrometry. The angiotensin converting enzyme inhibitory effect was evaluated in vivo by Ang I administration. The antihypertensive assay was performed in spontaneously hypertensive rats and Wistar rats that were treated with enalapril (10 mg/kg), the methanolic extract of C. papaya (100 mg/kg; twice a day), or vehicle for 30 days. The baroreflex was evaluated through the use of sodium nitroprusside and phenylephrine. Angiotensin converting enzyme activity was measured by ELISA, and cardiac hypertrophy was evaluated by morphometric analysis. The methanolic extract of C. papaya was standardised in ferulic acid (203.41 ± 0.02 µg/g), caffeic acid (172.60 ± 0.02 µg/g), gallic acid (145.70 ± 0.02 µg/g), and quercetin (47.11 ± 0.03 µg/g). The flavonoids quercetin, rutin, nicotiflorin, clitorin, and manghaslin were identified in a fraction of the extract. The methanolic extract of C. papaya elicited angiotensin converting enzyme inhibitory activity. The antihypertensive effects elicited by the methanolic extract of C. papaya were similar to those of enalapril, and the baroreflex sensitivity was normalised in treated spontaneously hypertensive rats. Plasma angiotensin converting enzyme activity and cardiac hypertrophy were also reduced to levels comparable to the enalapril-treated group. These results may be associated with the chemical composition of the methanolic extract of C. papaya, and are the first step into the development of a new phytotherapic product which could be used in the treatment of hypertension. * These two authors contributed equally to this work.

27 February 2015 in Therapeutic Advances in Cardiovascular Disease
Verified
Journal Article
Open access
SRSilas Nascimento Ronchi
Silas Nascimento Ronchi
GBGirlandia Alexandre Brasil
Girlandia Alexandre Brasil
ANAndrews Marques Do Nascimento
Andrews Marques Do Nascimento
ELEwelyne Miranda de Lima
Ewelyne Miranda de Lima
RSRodrigo Scherer
Rodrigo Scherer
TATadeu Andrade
Tadeu Andrade
The aim of this study was to investigate the antihypertensive effect of leaves Mangifera indica L. using in vitro and in vivo assays. The ethanol extract of leaves of M. indica was fractionated to dichloromethanic, n-butyl alcohol and aqueous fractions. The chemical composition of ethanolic extract and dichloromethanic fraction were evaluated by liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS). Antioxidant activity was evaluated in the DPPH scavenging activity assay. Angiotensin-converting enzyme (ACE) inhibitory activity was investigated using in vitro and in vivo assays. The chronic antihypertensive assay was performed in spontaneously hypertensive rats (SHRs) and Wistar rats treated with enalapril (10 mg/kg), dichloromethanic fraction (100 mg/kg; twice a day) or vehicle control for 30 days. The baroreflex sensitivity was evaluated through the use of sodium nitroprusside and phenylephrine. Cardiac hypertrophy was evaluated by morphometric analysis. The dichloromethanic fraction exhibited the highest flavonoid, total phenolic content and high antioxidant activity. Dichloromethanic fraction elicited ACE inhibitory activity in vitro (99 ± 8%) similar to captopril. LC-MS/MS analysis revealed the presence of ferulic acid (48.3 ± 0.04 µg/g) caffeic acid (159.8 ± 0.02 µg/g), gallic acid (142.5 ± 0.03 µg/g), apigenin (11.0 ± 0.01 µg/g) and quercetin (203.3 ± 0.05 µg/g). The chronic antihypertensive effects elicited by dichloromethanic fraction were similar to those of enalapril, and the baroreflex sensitivity was normalized in SHR. Plasma ACE activity and cardiac hypertrophy were comparable with animals treated with enalapril. Dichloromethanic fraction of M. indica presented an antihypertensive effect, most likely by ACE inhibition, with benefits in baroreflex sensitivity and cardiac hypertrophy. Altogether, the results of the present study suggest that the dichloromethanic fraction of M. indica leaves may have potential as a promoting antihypertensive agent.

17 September 2017 in Molecules
Verified
Journal Article
Open access
PDF file
TATadeu Andrade
Tadeu Andrade
GBGirlandia Alexandre Brasil
Girlandia Alexandre Brasil
Denise EndringerDenise Endringer
Denise Endringer
FNFlávio Rogério Da Nóbrega
Flávio Rogério Da Nóbrega
Damiao Pergentino de SousaDamiao Pergentino de Sousa
Damiao Pergentino de Sousa
Cardiovascular diseases are a leading cause of death in developed and developing countries and decrease the quality of life, which has enormous social and economic consequences for the population. Recent studies on essential oils have attracted attention and encouraged continued research of this group of natural products because of their effects on the cardiovascular system. The pharmacological data indicate a therapeutic potential for essential oils for use in the treatment of cardiovascular diseases. Therefore, this review reports the current studies of essential oils chemical constituents with cardiovascular activity, including a description of their mechanisms of action.

1 September 2015 in Life Sciences
Verified
Journal Article
Closed access
GBGirlandia Alexandre Brasil
Girlandia Alexandre Brasil
ELEwelyne Miranda de Lima
Ewelyne Miranda de Lima
ANAndrews Marques Do Nascimento
Andrews Marques Do Nascimento
ICIzabela Facco Caliman
Izabela Facco Caliman
AMAna Raquel Santos de Medeiros
Ana Raquel Santos de Medeiros
NBNazaré Souza Bissoli
Nazaré Souza Bissoli